SMRT Live Session: MR Contrast: An Update on MRI Contrast & Panel Discussion 1

SMRT Clinical Focus Session

MR Contrast: An Update on MRI Contrast & Panel Discussion 1

Back to Program-at-a-Glance

Session Topic: SMRT Live Q&A 2

Session Sub-Topic: Clinical Focus Session - MR Contrast: An Update on MRI Contrast & Panel Discussion 1

SMRT Ed Session

ORGANIZERS: Claire Mulcahy

SMRT Parallel Room 2 Live Q&A

Saturday, 8 August 2020, 19:45 - 20:30 UTC

Moderators: Adam Scotson

Session Number: SMRT-04

Overview
The safety of gadolinium (Gd) continues to be questioned especially with concerns around gadolinium deposition in the brain and body. The session will review current developments in contrast agent safety, including methods to reduce gadolinium dosage and the use of alternative contrast agents.

Target Audience
Radiographers, MR technologists, radiologists, clinicians, and scientists who utilise contrast agents for clinical or research applications

Educational Objectives
As a result of attending this course, participants should be able to:
1. Describe the perceived risks associated with gadolinium based contrast agents and review alternative contrast agent approaches.
2. Identify the minimum dosage of gadolinium based contrast agent recommended to ensure diagnostic value in MR images.
3. Review the usage of Ferumoxytol as a MR contrast agent in terms of sensitivity, availability and performance.

		Update on Gadolinium-Based Contrast Agent Safety Jeffrey Weinreb Watch the Video
		Gd: Minimising Dose Without Jeopardising Diagnosis Susie Huang Watch the Video The safety of gadolinium (Gd) continues to be questioned as concerns grow around gadolinium deposition in the brain and body. This lecture examines strategies for minimizing the dose of gadolinium in clinical practice without compromising diagnosis and management. The presentation will provide an overview of current approaches to avoid or decrease the use of gadolinium in the context of the clinical question that is posed. Emerging techniques for minimizing, if not eliminating, gadolinium will be discussed, and an outlook on the future of gadolinium usage in clinical examinations will be provided.
		To Contrast or Not to Contrast, That Is the Question: A Pediatric Perspective Michael Kean Watch the Video